Global Oral Inhalation Devices Market Anticipated to Reach USD 77,666.6 Million by 2030

According to a recent market study published by Growth Market Reports, titled, “Global Oral Inhalation Devices Market is segmented into by device type, by application, by distribution channel, and by region: Size, Share, Trends, and Opportunity Analysis, 2015-2030”, the market was valued at USD 43,743.3 Million in 2021 and is expected to grow at a growth rate of 6.5% by the year 2030.

Get Sample Report @ https://growthmarketreports.com/request-sample/5338

An inhaler is a device used to administer medication in the lungs and airways. It is primarily used to treat or prevent illnesses related to the airways such as cystic fibrosis, chronic obstructive pulmonary disease (COPD), and asthma. Drug delivery by inhalation is a preferred method of medication administration, as it assists high drug concentrations to reach locally within the lungs with reduced risk of side effects. A variety of medicines are available in an inhalable form.

On the basis of device type, the global oral inhalation devices market is segregated into nebulizers, metered dose inhalers (MDI), dry powder inhalers (DPI), and others (soft mist inhalers and smart inhalers). The metered dose inhalers (MDI) segment is expected to register high growth during the forecast period, as these inhalers are small, portable, and easy to handle. They release a consistent amount of medicine. These inhalers usually contain 200 or 120 doses in one canister.

Based on application, the global oral inhalation devices market is segmented into asthma, chronic obstructive pulmonary disease (COPD), and others (cystic fibrosis and idiopathic pulmonary fibrosis).

In terms of distribution channel, the global oral inhalation devices market is bifurcated into retail pharmacy, hospital pharmacy, and online pharmacy. The online pharmacy segment is the fastest-growing segment, due to the increasing technological innovations in the supply of contactless medicine, which was helpful, especially during the pandemic.

The outbreak of Coronavirus in 2019 (COVID-19) boosted the global oral inhalation devices market. The adoption of preventive measures to curb the spread of the disease were required during the pandemic. These factors drove the demand for oral inhalation devices in hospitals and clinics. The pandemic propelled the healthcare industry to take emergency actions to develop both therapeutic and protective interventions. Also, many pharmaceutical companies are concentrating on developing effective treatments to treat COVID-19, which are primarily administered through a nebulizer for asthma and COPD patients.

As per growth market reports by industry analyst Divyanka Sankhe, “The pharmaceutical industry is implementing changes in technology for inhalation devices. For instance, advances in metered dose inhalation devices by incorporating small microprocessors into the inhalers allow the inhalation to be controlled and monitored. Technological innovations in inhaler device products category have improved the accuracy and precision of dosing and improved the quality of the product.”

Supply chain management is a vital part of any business. A supply chain contains a series of steps to get products from their original state to final products to the customers. Raw materials used for manufacturing oral inhalation devices are transported to manufacturers to be processed into final products. A metal canister made with aluminum or stainless steel, an actuator made with plastic, a metering valve, and polypropylene are some of the raw materials used in the production of inhaler devices.

Key Takeaways from the Study

The players in the global oral inhalation devices market include Koninklijke Philips N.V.; AptarGroup, Inc.; Chiesi Farmaceutici S.p.A.; OMRON Healthcare, Inc.; Recipharm AB; KINDEVA DRUG DELIVERY; Beurer GmbH; PARI Respiratory Equipment, Inc.; Vincent Medical Holdings Limited; and Trudell Medical International (Monaghan Medical Corporation).

Target Audience

• Supply-side: Manufacturer and Distributors.
• Demand Side: Hospitals, Patients with Respiratory Diseases
• Regulatory Side: Approved Regulatory Bodies.
• Associations and Industry Bodies: American Lung Association (ALA), Asthma and Allergy Foundation of America, Indian Association of Respiratory Care (IARC), World Health Organization (WHO), and others.